Coulter & Justus Financial Services’s AstraZeneca AZN Stock Holding History

Coulter & Justus Financial Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$339K	Buy	+2,505	New	+$332K	0.08%	74

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Coulter & Justus Financial Services's AZN Position: Q1 2024 in Review

Coulter & Justus Financial Services opened a new position in AstraZeneca (AZN) in Q1 2024: 2,505 shares worth $339K. The stake represents 0.08% of the portfolio and ranks #74 among its holdings.

1,141 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

Coulter & Justus Financial Services held 2,505 shares of AstraZeneca worth $339K as of Q1 2024.
AstraZeneca was a new Coulter & Justus Financial Services position in Q1 2024.
AstraZeneca made up 0.08% of Coulter & Justus Financial Services's portfolio in Q1 2024, its #74 holding.
1,141 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Coulter & Justus Financial Services's 13F filing for Q1 2024, filed 3 May 2024.